Hyperion DeFi (NASDAQ:HYPD) Stock Rating Upgraded by Zacks Research

Hyperion DeFi (NASDAQ:HYPD) was upgraded by equities researchers at Zacks Research to a “hold” rating in a report released on Monday,Zacks.com reports.

Several other brokerages have also commented on HYPD. Weiss Ratings restated a “sell (d-)” rating on shares of Hyperion DeFi in a research note on Wednesday, October 8th. Wall Street Zen raised shares of Hyperion DeFi from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Cantor Fitzgerald began coverage on Hyperion DeFi in a report on Tuesday, December 16th. They issued an “overweight” rating and a $4.00 price target for the company. Finally, Chardan Capital set a $7.75 target price on Hyperion DeFi and gave the company a “buy” rating in a research note on Wednesday, December 24th. Two investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Hyperion DeFi has a consensus rating of “Hold” and an average target price of $4.58.

Hyperion DeFi Stock Down 3.7%

Shares of NASDAQ:HYPD opened at $3.37 on Monday. The company has a quick ratio of 2.25, a current ratio of 2.25 and a debt-to-equity ratio of 0.11. The firm’s 50-day simple moving average is $4.79 and its 200-day simple moving average is $7.60. Hyperion DeFi has a fifty-two week low of $0.85 and a fifty-two week high of $17.99. The company has a market cap of $27.54 million, a price-to-earnings ratio of -0.83 and a beta of 2.80.

Hyperion DeFi (NASDAQ:HYPD) last announced its quarterly earnings results on Friday, November 14th. The company reported $0.05 earnings per share (EPS) for the quarter. Hyperion DeFi had a negative net margin of 62,238.41% and a negative return on equity of 119.59%. The business had revenue of $0.36 million during the quarter. As a group, equities research analysts predict that Hyperion DeFi will post -41.6 earnings per share for the current year.

Insider Transactions at Hyperion DeFi

In other Hyperion DeFi news, Director Happy David Walters acquired 61,930 shares of Hyperion DeFi stock in a transaction dated Wednesday, December 17th. The stock was bought at an average cost of $3.02 per share, with a total value of $187,028.60. Following the completion of the transaction, the director owned 111,930 shares of the company’s stock, valued at $338,028.60. The trade was a 123.86% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Ellen R. Strahlman purchased 19,702 shares of the stock in a transaction that occurred on Thursday, December 18th. The shares were purchased at an average price of $3.14 per share, for a total transaction of $61,864.28. Following the completion of the purchase, the director directly owned 95,150 shares of the company’s stock, valued at approximately $298,771. This trade represents a 26.11% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 161,254 shares of company stock worth $511,126 in the last 90 days. 10.86% of the stock is owned by insiders.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.